Pfizer supports Investigator Sponsored Research (ISR) projects that advance medical and scientific knowledge about our therapies. An ISR is a type of grant that supports an independent research study where the investigator or organization is the sponsor of the study and where Pfizer provides financial and/or non-financial support for the development or refinement of specific and defined medical knowledge relating to a Pfizer asset. This global program is open to all researchers who are interested in conducting their own research.
Studies that will be considered for Pfizer financial and non-financial support will focus on generating evidence on priority gaps in the use of elranatamab in multiple myeloma across lines of treatment.
Application submission deadline: July 18, 2024
Geographic Scope : Global
• Only organizations are eligible to receive grants, not individuals or medical practice groups (i.e., an independent group of physicians not affiliated with a hospital, academic institution, or professional society). • The PI must have a medical or postdoctoral degree (MD, PhD, or equivalent), an advanced nursing degree (e.g. BSN with a MS/PhD), or a terminal degree in Pharmacy or other healthcare field. • The grant applicant must be the PI or an authorized designee of such individual (e.g., PI’s research coordinator). • The PI must be an employee or contractor of the requesting organization. • Requesting organization must be legally able to receive award funding directly from Pfizer Inc. We strongly recommend that applicants confirm this with their organization or institution prior to submitting an application.
• Individual study grant requests up to $1.5 million USD will be considered, although smaller requests (around $500,000) are also encouraged.